Imidazo[2,1-b]thiazepines:: synthesis, structure and evaluation of benzodiazepine receptor binding

被引:14
作者
Kiec-Kononowicz, K
Karolak-Wojciechowska, J
Michalak, B
Pekala, E
Schumacher, B
Müller, CE
机构
[1] Jagiellonian Univ, Coll Med, Dept Chem Technol Drugs, PL-30688 Krakow, Poland
[2] Tech Univ Lodz, Inst Gen & Ecol Chem, PL-90924 Lodz, Poland
[3] Univ Bonn, Pharmaceut Inst Poppelsdorf, D-53115 Bonn, Germany
关键词
benzodiazepine receptor; GABA(A) receptor; imidazo[2,1-b]thiazepines; structure-activity relationships; X-ray structure analysis;
D O I
10.1016/j.ejmech.2003.11.009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As a continuation of our search for new ligands acting on benzodiazepine receptors among the fused 2-thiohydantoin derivatives, a series of 5-substituted imidazo[2.1-b]thiazepines was synthesized and investigated in radioligand binding studies at the benzodiazepine binding site of GABA, receptors in rat brain cortical membranes. Among ortho-substituted 5-arylidene-imidazo[2, 1-b]thiazepines compounds could be identified which exhibit affinity for the benzodiazepine binding site at low micromolar concentrations. X-ray structure analyses for two compounds (6ae and 6ag) have been performed. In order to analyze the structure-activity relationships, 3D models of all compounds have been completed (using X-ray data). Physicochemical properties calculated (log P and log D) as well as experimental thin layer chromatogra-phy data were examined. (C) 2003 Elsevier SAS. All rights reserved.
引用
收藏
页码:205 / 218
页数:14
相关论文
共 41 条
[21]  
Malawska B, 1998, JPC-J PLANAR CHROMAT, V11, P137
[22]   POTENTIAL ANXIOLYTIC AGENTS - PYRIDO[1,2-A]BENZIMIDAZOLES - A NEW STRUCTURAL CLASS OF LIGANDS FOR THE BENZODIAZEPINE BINDING-SITE ON GABA-A RECEPTORS [J].
MARYANOFF, BE ;
HO, W ;
MCCOMSEY, DF ;
REITZ, AB ;
GROUS, PP ;
NORTEY, SO ;
SHANK, RP ;
DUBINSKY, B ;
TAYLOR, RJ ;
GARDOCKI, JF .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (01) :16-20
[23]   Which GABA(A)-receptor subtypes really occur in the brain? [J].
McKernan, RM ;
Whiting, PJ .
TRENDS IN NEUROSCIENCES, 1996, 19 (04) :139-143
[24]  
MICHALAK B, 2000, P 2 MULT C DRUG RES
[25]  
NICKEL PV, 1997, BURGERS MED CHEM DRU, P159
[26]   NEW PERSPECTIVES IN BENZODIAZEPINE RECEPTOR PHARMACOLOGY [J].
PETERSEN, EN ;
JENSEN, LH ;
DREJER, J ;
HONORE, T .
PHARMACOPSYCHIATRY, 1986, 19 (01) :4-6
[27]   ANTIEPILEPTIC DRUG DEVELOPMENT PROGRAM [J].
PORTER, RJ ;
CEREGHINO, JJ ;
GLADDING, GD ;
HESSIE, BJ ;
KUPFERBERG, HJ ;
SCOVILLE, B ;
WHITE, BG .
CLEVELAND CLINIC QUARTERLY, 1984, 51 (02) :293-305
[28]   3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones:: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands [J].
Primofiore, G ;
Da Settimo, F ;
Taliani, S ;
Marini, AM ;
La Motta, C ;
Novellino, E ;
Greco, G ;
Gesi, M ;
Trincavelli, L ;
Martini, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (01) :96-102
[29]   Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes [J].
Rudolph, U ;
Crestani, F ;
Benke, D ;
Brünig, I ;
Benson, JA ;
Fritschy, JM ;
Martin, JR ;
Bluethmann, H ;
Möhler, H .
NATURE, 1999, 401 (6755) :796-800
[30]   γ-Aminobutyrate-A receptor modulation by 3-aryl-1-(arylsulfonyl)-1,4,5,6-tetrahydropyridazines [J].
Rybczynski, PJ ;
Combs, DW ;
Jacobs, K ;
Shank, RP ;
Dubinsky, B .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (13) :2403-2408